Skip to content
Catalyst

lactoferrinFinding

Lactoferrin has no detected effect on all-cause mortality

no difference foundModerate evidenceFinding

01 · The sentence it was drawn from

“Likewise, we did not detect any lactoferrin effects on the need for oxygen supplementation and its duration, non-invasive or mechanically assisted ventilation, or in-hospital mortality at 14 and 28 days from admission (Table 4).”
Quoted verbatim from Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial.
This finding among the 161 findings on its endpoint

lactoferrin

All-cause mortality

no difference found

Who
Adults hospitalised in non-ICU wards with moderate-to-severe COVID-19 at two Italian hospitals, standard COVID-19 therapy in both arms; in-hospital mortality at 14 and 28 days
Dose studied
800 mg/day bovine lactoferrin, 2 capsules of 200 mg every 12 h before meals, for 30 days

Moderate evidencePMID 36904283 · 2023

02 · The study

Study
RCT
Duration
4 weeks

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7MB3V3ZER6H25MT5RQQ3AJA